This Phase 3, randomized, open-label, multicenter study conducted at 44 sites in Europe evaluated the safety and efficacy of a continuous, daily regimen of levonorgestrel (LNG) 90 mcg/ethinyl estradiol (EE) 20 mcg compared with a 21-day, cyclic LNG 100 mcg/EE 20 mcg regimen.
Three hundred twenty-three healthy women were randomized to continuous LNG 90 mcg/EE 20 mcg and 318 subjects to cyclic LNG 100 mcg/EE 20 mcg for 1 year (13 pill packs). Pearl index, adverse event (AE) incidence and bleeding profiles were assessed.
No pregnancies occurred with the continuous oral contraceptive (OC) (Pearl index=0.00). As the study progressed, the percentage of women who achieved amenorrhea during each 28-day pill pack increased: 40% at pill pack 7, 53% at pill pack 13. The percentage of women with no bleeding [with or without spotting (defined as not requiring sanitary protection)] was 50%, 69% and 79% at pill packs 3, 7 and 13, respectively. The incidence of AEs was similar to that of the cyclic OC (except for metrorrhagia and vaginal bleeding in the first 6 months).
Continuous LNG 90 mcg/EE 20 mcg was shown to be a safe and effective OC in this direct comparison to a cyclic OC. Suppression of menses and the potential for no bleeding requiring sanitary protection may be provided by this continuous, low-dose OC.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regiment.Br Med J. 1977; 2: 487-490
- A trimonthly regimen for oral contraceptives.Br J Fam Plann. 1994; 19: 274-275
- A multicenter, randomized study of an extended cycle of oral contraceptive.Contraception. 2003; 68: 89-96
- Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives.Contraception. 2004; 70: 359-363
- Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.Contraception. 2004; 69: 37-42
- Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.Contraception. 1999; 59: 357-362
- What is the desired menstrual frequency of women without menstruation-related symptoms?.Contraception. 2006; 73: 537-541
- Amenorrhea associated with contraception — an international study on acceptability.Contraception. 2003; 67: 1-8
Archer DF, Kovalevsky G, Ballagh S, Grubb GS. Effect on ovarian activity of a novel levonorgestrel/ethinyl estradiol oral contraceptive regimen. Fertil Steril [Epub ahead of print, May 4, 2009].
- The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and research training in human reproduction.Contraception. 1986; 34: 253-260
U.S. Food and Drug Administration. Depot medroxyprogesterone, summary basis of approval, medical review. October 27, 1992.
- Contraceptive efficacy and safety of DMPA-SC.Contraception. 2004; 70: 269-275
- Evaluation of a continuous regiment of levonorgestrel/ethinyl estradiol: phase 3 study results.Contraception. 2006; 74: 439-445
- Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use.Contraception. 2006; 73: 235-243
- Effects of continuous versus cyclical oral contraception: a randomized controlled trial.J Clin Endocrinol Metab. 2008; 93: 420-429
- Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.Am J Obstet Gynecol. 2004; 190: 943-951
- Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse).Am J Obstet Gynecol. 1999; 181: S39-S44
- Canadian Consensus Guideline on Continuous and Extended Hormonal Contraception, 2007.J Obstet Gynaecol Can. 2007; 29: S1-S32
- Return to fertility after cessation of a continuous oral contraceptive.Fertil Steril. 2009; 91: 1654-1656
- Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg.Contraception. 2007; 75: 23-26
- Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.Obstet Gynecol. 2003; 101: 653-661
Published online: August 07, 2009
Accepted: May 22, 2009
Received in revised form: May 22, 2009
Received: November 25, 2008
☆This study was sponsored by Wyeth Research, Collegeville, PA.
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.